C o r r e s p o n d e n c e

Vaccination Rates among Younger Siblings of Children with Autism
To the Editor: Recent outbreaks of illnesses that may be prevented by vaccines have increased public debate about vaccination behaviors (i.e., whether or not and when parents choose to vaccinate a child), and California has been a key affected state. One reason that parents choose not to have their children vaccinated is the perceived link between vaccines and autism spectrum disorder. This reason is particularly relevant for parents of a child who has autism spectrum disorder, since concerns that the disorder will develop in subsequent children may be more pronounced.
Since 2009, we have tracked the development of infants who have a full biologic older sibling with a diagnosis of autism spectrum disorder. The risk of this disorder is increased by a factor of approximately 20 among these "high-risk" infants. 1 Our comparisons of such infants with age-matched "low-risk" infants who have an older sibling without autism spectrum disorder allows for the identification of putative biomarkers of this disorder. 2 Although vaccination behaviors were not our primary focus, studies showing decreased rates of vaccination against measles-mumps-rubella (MMR) among high-risk infants prompted us to analyze available data on vaccination behaviors in our sample of 206 families from southern California (71 of which had a child with autism spectrum disorder and 135 that did not have a child with autism spectrum disorder) (Table 1) . 3, 4 Childhood vaccination and autism spectrum disorder continue to be linked in the minds of many people despite overwhelming evidence to the contrary. 5 Adding to this evidence, our data showed no significant difference between rates of vaccination among children with and those without autism (100.0% vs. 98.5%; P = 0.30). However, there were two additional interesting findings. Families with children who had autism spectrum disorder were less likely to vaccinate subsequent children. Specifically, the rate of vaccination among full biologic infant siblings of children with autism spectrum disorder was 83.1%, as compared with 97.0% among low-risk infants (Pearson chi-square value with one degree of freedom, 12.62; P<0.001). These findings are consistent with reported rates of MMR vaccination among children at older ages and across broader sampling regions. 3, 4 Our results also suggest that changes in vaccination behavior may relate to adverse reactions to vaccine. In particular, parents who had an older child with autism spectrum disorder retrospectively reported a higher rate of adverse reactions to vaccination among the older child than did those who did not have an older child with autism (22.6% vs. 3.8%; Pearson chi-square value with one degree of freedom, 16.87; P<0.001). Likewise, parents who had an older child with autism retrospectively reported a higher rate of these reactions among the infant sibling than this week's letters Older siblings are the closest sibling in age to the infant, with the exception of seven older siblings in the autism spectrum disorder group. Student's t-tests were performed to compare ages across groups, with Welch's correction to adjust for unequal variances in comparisons of older siblings and infants. Categorical data are shown as a percentage for each group, and chi-square analyses were used to investigate differences between the groups. The following data were missing and were therefore excluded from analyses: race (1 child-infant pair in the low-risk group), ethnic group (2 in the low-risk group and 3 in the high-risk group), education (1 in the low-risk group), and maternal age (1 in the high-risk group). In addition, the presence of "0" values in some cells resulted in exclusion of the variables "black" and "less than high school" from group comparisons. Since the sample included only full biologic siblings, categorical data for the older sibling and infant counterpart are identical, except for sex. Older siblings with autism spectrum disorder were more likely to be male than typically developing older siblings (P<0.001). P ≥ 0.10 for all other comparisons. † Race or ethnic group was reported by the parents, who could report more than one race or ethnic group. report that head positioning did not influence outcome in patients with acute stroke. The lyingflat position theoretically increases cerebral perfusion, which may alleviate acute ischemia through the recruitment of collaterals. 2 However, in the Head Positioning in Acute Stroke Trial (HeadPoST), reported by Anderson et al., many patients had conditions that presumably were not the result of large perfusion defects: specifically, there were patients with stroke mimics (4.9%), lacunar stroke (30.2%), or intracerebral hemorrhage (8.4%). Moreover, the low median scores on the National Institutes of Health Stroke Scale in both study groups 1 suggest that few patients had proximal occlusions of the intracranial arteries, which implies that many patients did not require improvement in their collateral cerebrovascular network during acute stroke. The absence of large ischemic stroke has been proposed as a possible reason for the failure of endovascular therapy to show clinical benefit in some recent trials. 3, 4 Head positioning therefore might be evaluated in a more selective population, such as patients with large strokes or large ischemic areas at risk, 5 before we give up on this nonpharmacologic strategy. Igor Sibon, M.D., Ph.D. No potential conflict of interest relevant to this letter was reported.
